Valeant Tells Regulators Allergan Is Misleading Investors
Valeant Pharmaceuticals International Inc. said Monday it has contacted U.S. and Canadian regulators saying Allergan Inc., the Botox maker and target of it and activist investor Bill Ackman's $53 billion takeover,...To view the full article, register now.
Already a subscriber? Click here to view full article